PMID- 29570819
OWN - NLM
STAT- MEDLINE
DCOM- 20190618
LR  - 20190618
IS  - 1440-1681 (Electronic)
IS  - 0305-1870 (Linking)
VI  - 45
IP  - 8
DP  - 2018 Aug
TI  - Hyperuricaemia and type 2 diabetes mellitus.
PG  - 870
LID - 10.1111/1440-1681.12937 [doi]
AB  - Choi et al reported the effect of hyperuricaemia on the new-onset type 2 diabetes 
      mellitus (T2DM). I present three queries. (i) Insulin is considered to stimulate 
      uric acid reabsorption via specific transporter and the effect of hyperuricaemia 
      on the new-onset T2DM should be evaluated by considering insulin resistance. (ii) 
      There is a limitation in the number of events for stable estimates. (iii) Obesity 
      and sex should be considered for the analysis.
CI  - (c) 2018 John Wiley & Sons Australia, Ltd.
FAU - Kawada, Tomoyuki
AU  - Kawada T
AUID- ORCID: 0000-0002-4426-4644
AD  - Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan.
LA  - eng
PT  - Comment
PT  - Letter
PL  - Australia
TA  - Clin Exp Pharmacol Physiol
JT  - Clinical and experimental pharmacology & physiology
JID - 0425076
RN  - 0 (Insulin)
RN  - 268B43MJ25 (Uric Acid)
SB  - IM
CON - Clin Exp Pharmacol Physiol. 2018 Jun;45(6):499-506. PMID: 29266345
MH  - *Diabetes Mellitus, Type 2
MH  - Humans
MH  - *Hyperuricemia
MH  - Insulin
MH  - *Insulin Resistance
MH  - Uric Acid
OTO - NOTNLM
OT  - hyperuricaemia
OT  - prospective study
OT  - type 2 diabetes mellitus
EDAT- 2018/03/24 06:00
MHDA- 2019/06/19 06:00
CRDT- 2018/03/24 06:00
PHST- 2018/02/20 00:00 [received]
PHST- 2018/03/13 00:00 [accepted]
PHST- 2018/03/24 06:00 [pubmed]
PHST- 2019/06/19 06:00 [medline]
PHST- 2018/03/24 06:00 [entrez]
AID - 10.1111/1440-1681.12937 [doi]
PST - ppublish
SO  - Clin Exp Pharmacol Physiol. 2018 Aug;45(8):870. doi: 10.1111/1440-1681.12937.